Many biology labs fight with a glut of measurement data. New software aims to make this a thing of the past: it simplifies laboratory experiment evaluation and unifies how data is saved. It even identifies measurement errors on the spot.
During laboratory testing, countless measurement results accrue. To completely and systematically archive this body of data is extremely time consuming. In fact, researchers in the life sciences spend a quarter of their time managing data, according to an online survey of 70 people working in biology laboratories conducted by the Fraunhofer Institute for Applied Information Technology FIT in Sankt Augustin. Many of those surveyed reported that they have no centralized or structured approach to data collection in their workplace. And when a PhD student or assistant with years of experience leaves the institute and the successor tries to find and make sense of previous results, the search often begins with cryptic Excel tables and stacks of paper.
The FIT has taken steps to alleviate this problem. With its step-by-step operation, its “MPlexAnalyzer” software makes it considerably easier to manage data. Initially, the FIT experts concentrated on cytometric devices, which enable the simultaneous determination of a variety of proteins in a test batch. This approach, also called a cytometric multiplex assay, is a standard method in every biology lab. However, assays such as these are very complex and produce huge amounts of data, so it is no wonder that personnel without access to any supporting software often lose the upper hand with data collection. The FIT software’s wizard assistant guides users through the entire measurement process, starting with the selection of the microtiter plates, the choice of samples, and the assignment of standard samples, and provides a clearly arranged PDF report for print out; the process is transparent and easy for beginners to grasp quickly.
The Latest on: Biology lab data
via Google News
The Latest on: Biology lab data
- The state of AI in 2020: Biology and healthcare's AI moment, ethics, predictions, and graph neural networkson October 12, 2020 at 7:46 am
Research and industry breakthroughs, ethics, and predictions. This is what AI looks like today, and what it's likely to look like tomorrow.
- Lab-Made ‘Miniproteins’ Could Block the Coronavirus from Infecting Cellson October 12, 2020 at 4:40 am
Monoclonal antibodies—a potentially promising laboratory-manufactured therapy modeled on antibodies ... design more than two million candidate “miniproteins,” crunched the data using algorithms, ...
- Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & Moreon October 9, 2020 at 8:11 am
It’s October: a time of days growing shorter, leaves changing color, and phone calls in the wee hours that rouse scientists from slumber notifying them ...
- Bio-Rad Launches Two New qPCR Systems, Data Management Softwareon October 8, 2020 at 2:10 pm
Company releases CFX Opus 96 and CFX Opus 384 real-time PCR systems along with BR.io, a cloud-based instrument connectivity, data management, and analysis platform ...
- Mustang Bio Announces MB-105 Data Selected for Presentation at the Virtual 27th Annual Prostate Cancer Foundation Scientific Retreaton October 8, 2020 at 5:15 am
Manuel Litchman, M.D., President and Chief Executive Officer of Mustang, said, “We are pleased that City of Hope will be presenting initial data from the Phase 1 trial of MB-105 at the v. MB-105 is ...
- Deep learning takes on synthetic biologyon October 7, 2020 at 2:00 am
Two teams of scientists from the Wyss Institute at Harvard University and the Massachusetts Institute of Technology have devised pathways around this roadblock by going beyond human brains; they ...
- Data Under Attack During COVID-19on October 6, 2020 at 4:34 pm
Sandia National Laboratories and IQVIA are among the biotech organizations that are working to safeguard sensitive biological data from cybercriminals ...
- Sandia Helps Safeguard Biological Data Threatened During COVID-19 Pandemicon October 6, 2020 at 2:46 am
A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment has become more relevant after the United States and others ...
- bluebird bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application (MAA) for elivaldogene autotemcel (eli-cel, Lenti-D™) Gene Therapy for ...on October 2, 2020 at 4:30 am
EMA's acceptance of Marketing Authorization Application (MAA) for elivaldogene autotemcel gene therapy for CALD.
- How scientific leaders can enact anti-racist action in their labson October 1, 2020 at 11:14 am
A new paper provides 10 steps that principal investigators (PIs) and research group leaders can follow to help cultivate anti-racist professional and learning environments. V. Bala Chaudhary of DePaul ...
via Bing News